logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Khan, Imran Ahmed
    Individual (1 offspring)
    Officer
    icon of calendar 2021-08-01 ~ now
    OF - Secretary → CIF 0
  • 2
    Dale, Mark Christopher, Dr
    Born in May 1961
    Individual (27 offsprings)
    Officer
    icon of calendar 2015-03-31 ~ now
    OF - Director → CIF 0
  • 3
    MAC RESEARCH LTD
    icon of address19, Park Road, Lytham St. Annes, England
    Active Corporate (3 parents, 7 offsprings)
    Profit/Loss (Company account)
    27,873 GBP2023-07-01 ~ 2024-06-30
    Person with significant control
    icon of calendar 2016-11-12 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

MAC CLINICAL RESEARCH FINANCE LTD

Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Cost of Sales
-2,258,885 GBP2023-07-01 ~ 2024-06-30
-2,260,470 GBP2022-07-01 ~ 2023-06-30
Administrative Expenses
-22,127,045 GBP2023-07-01 ~ 2024-06-30
-19,858,194 GBP2022-07-01 ~ 2023-06-30
Other Interest Receivable/Similar Income (Finance Income)
30,331 GBP2023-07-01 ~ 2024-06-30
36,568 GBP2022-07-01 ~ 2023-06-30
Profit/Loss on Ordinary Activities Before Tax
-1,808,769 GBP2023-07-01 ~ 2024-06-30
558,871 GBP2022-07-01 ~ 2023-06-30
Profit/Loss
880,150 GBP2023-07-01 ~ 2024-06-30
2,303,535 GBP2022-07-01 ~ 2023-06-30
Comprehensive Income/Expense
880,150 GBP2023-07-01 ~ 2024-06-30
2,303,535 GBP2022-07-01 ~ 2023-06-30
Intangible Assets
Other
775,355 GBP2024-06-30
491,488 GBP2023-06-30
Property, Plant & Equipment
1,846,067 GBP2024-06-30
1,272,711 GBP2023-06-30
Fixed Assets - Investments
4,037,816 GBP2024-06-30
1,311,908 GBP2023-06-30
Fixed Assets
6,659,238 GBP2024-06-30
3,076,107 GBP2023-06-30
Debtors
10,848,085 GBP2024-06-30
10,380,520 GBP2023-06-30
Cash at bank and in hand
251 GBP2024-06-30
2,335,349 GBP2023-06-30
Current Assets
10,848,336 GBP2024-06-30
12,715,869 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-6,402,455 GBP2024-06-30
Net Current Assets/Liabilities
4,445,881 GBP2024-06-30
6,541,488 GBP2023-06-30
Total Assets Less Current Liabilities
11,105,119 GBP2024-06-30
9,617,595 GBP2023-06-30
Creditors
Non-current, Amounts falling due after one year
-668,817 GBP2024-06-30
-425,126 GBP2023-06-30
Net Assets/Liabilities
10,053,869 GBP2024-06-30
9,192,469 GBP2023-06-30
Equity
Called up share capital
10 GBP2024-06-30
10 GBP2023-06-30
10 GBP2022-06-30
Retained earnings (accumulated losses)
10,053,859 GBP2024-06-30
9,192,459 GBP2023-06-30
6,907,674 GBP2022-06-30
Equity
10,053,869 GBP2024-06-30
9,192,469 GBP2023-06-30
Profit/Loss
Retained earnings (accumulated losses)
880,150 GBP2023-07-01 ~ 2024-06-30
2,303,535 GBP2022-07-01 ~ 2023-06-30
Dividends Paid
Retained earnings (accumulated losses)
-18,750 GBP2022-07-01 ~ 2023-06-30
Dividends Paid
-18,750 GBP2023-07-01 ~ 2024-06-30
Audit Fees/Expenses
17,500 GBP2023-07-01 ~ 2024-06-30
12,200 GBP2022-07-01 ~ 2023-06-30
Average Number of Employees
3652023-07-01 ~ 2024-06-30
3512022-07-01 ~ 2023-06-30
Wages/Salaries
15,058,195 GBP2023-07-01 ~ 2024-06-30
13,761,643 GBP2022-07-01 ~ 2023-06-30
Staff Costs/Employee Benefits Expense
16,640,629 GBP2023-07-01 ~ 2024-06-30
15,205,567 GBP2022-07-01 ~ 2023-06-30
Director Remuneration
18,000 GBP2023-07-01 ~ 2024-06-30
10,800 GBP2022-07-01 ~ 2023-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
145,945 GBP2023-07-01 ~ 2024-06-30
0 GBP2022-07-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Computer software
967,351 GBP2024-06-30
683,484 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
Improvements to leasehold property
536,780 GBP2024-06-30
467,983 GBP2023-06-30
Plant and equipment
3,746,200 GBP2024-06-30
2,744,265 GBP2023-06-30
Motor vehicles
20,500 GBP2024-06-30
20,500 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
4,303,480 GBP2024-06-30
3,232,748 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
347,914 GBP2024-06-30
288,261 GBP2023-06-30
Plant and equipment
2,088,999 GBP2024-06-30
1,651,276 GBP2023-06-30
Motor vehicles
20,500 GBP2024-06-30
20,500 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,457,413 GBP2024-06-30
1,960,037 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
59,653 GBP2023-07-01 ~ 2024-06-30
Plant and equipment
437,723 GBP2023-07-01 ~ 2024-06-30
Motor vehicles
0 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
497,376 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment
Improvements to leasehold property
188,866 GBP2024-06-30
179,722 GBP2023-06-30
Plant and equipment
1,657,201 GBP2024-06-30
1,092,989 GBP2023-06-30
Motor vehicles
0 GBP2024-06-30
0 GBP2023-06-30
Other Investments Other Than Loans
Non-current
2,237,552 GBP2024-06-30
0 GBP2023-06-30
Amounts invested in assets
Non-current
4,037,816 GBP2024-06-30
1,311,908 GBP2023-06-30
Trade Debtors/Trade Receivables
Current
4,652,911 GBP2024-06-30
4,049,950 GBP2023-06-30
Amount of corporation tax that is recoverable
Current
2,764,384 GBP2024-06-30
1,744,664 GBP2023-06-30
Other Debtors
Current
2,241,305 GBP2024-06-30
1,715,892 GBP2023-06-30
Prepayments/Accrued Income
Current
666,746 GBP2024-06-30
679,753 GBP2023-06-30
Debtors
Current, Amounts falling due within one year
10,848,085 GBP2024-06-30
Amounts falling due within one year, Current
10,380,520 GBP2023-06-30
Bank Borrowings/Overdrafts
Current
791,578 GBP2024-06-30
0 GBP2023-06-30
Finance Lease Liabilities - Total Present Value
Current
222,375 GBP2024-06-30
114,515 GBP2023-06-30
Trade Creditors/Trade Payables
Current
2,837,315 GBP2024-06-30
1,758,891 GBP2023-06-30
Amounts owed to group undertakings
Current
511,646 GBP2024-06-30
472,849 GBP2023-06-30
Other Creditors
Current
83,858 GBP2024-06-30
54,756 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
1,955,683 GBP2024-06-30
3,773,370 GBP2023-06-30
Creditors
Current
6,402,455 GBP2024-06-30
6,174,381 GBP2023-06-30
Finance Lease Liabilities - Total Present Value
Non-current
668,817 GBP2024-06-30
425,126 GBP2023-06-30
Bank Overdrafts
791,578 GBP2024-06-30
0 GBP2023-06-30
Total Borrowings
Current
791,578 GBP2024-06-30
0 GBP2023-06-30
Minimum gross finance lease payments owing
Amounts falling due within one year
222,375 GBP2024-06-30
114,515 GBP2023-06-30
Minimum gross finance lease payments owing
891,192 GBP2024-06-30
539,641 GBP2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
387,982 GBP2024-06-30
556,732 GBP2023-06-30
Between two and five year
398,021 GBP2024-06-30
750,003 GBP2023-06-30
More than five year
63,000 GBP2024-06-30
99,000 GBP2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
849,003 GBP2024-06-30
1,405,735 GBP2023-06-30
Related profiles found in government register
  • MAC CLINICAL RESEARCH FINANCE LTD
    Info
    Registered number 09518942
    icon of address19 Park Road, Lytham St. Annes, Lancashire FY8 1PW
    PRIVATE LIMITED COMPANY incorporated on 2015-03-31 (10 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-16
    CIF 0
  • MAC CLINICAL RESEARCH FINANCE LTD
    S
    Registered number 09518942
    icon of address19, Park Road, Lytham St. Annes, Lancashire, England, FY8 1PW
    Private Limited Company in Companies House, England
    CIF 1
  • MAC CLINICAL RESEARCH FINANCE LTD
    S
    Registered number 9518942
    icon of address19, Park Road, Lytham St. Annes, London, State * *, United Kingdom, FY8 1PW
    Limited Company in Companies House, England
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    RCS NEWCO LIMITED - 2020-06-01
    icon of addressGround Floor, Fleming Pavilion Todd Campus, West Of Scotland Science Park, Glasgow, Scotland
    Active Corporate (2 parents)
    Equity (Company account)
    30,956 GBP2024-06-30
    Person with significant control
    icon of calendar 2024-03-15 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
  • 2
    MAC GROUP LTD - 2017-02-10
    icon of address19 Park Road, Lytham St. Annes, Lancashire, United Kingdom
    Active Corporate (3 parents)
    Equity (Company account)
    10 GBP2024-06-30
    Person with significant control
    icon of calendar 2022-01-10 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.